Form D · Other
Optherium Labs OU
Tallinn, 1H · CIK 0001739418
Offering snapshot reported May 15, 2018 · SEC filing
- Reported sold
- Yet to sell Offering amount: $234M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-312379
This offering will be made under a claim of federal exemption under Rule 506(c) and/or Regulation S under the Securities Act of 1933. The issuer may pursue one or more subsequent offerings, in which case a new or amended Form D will be filed.
Purchase and sale of OPEX tokens
Source: Form D, filed May 15, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sergey Bekiyants | Director, Executive |
| Rajavelu Dharmaraj | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
K379, Roosikrantsi 2
Tallinn, 1H, 10119
Tallinn, 1H, 10119